Wednesday - November 4, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Ong Tien USA
November 04, 2026
WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Ong Tien USA LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Ong Tien USA LLC, 11209 Bellaire Blvd, Houston, TX 77072-2536, United States, ongtienlinhchi@gmail.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER

Refer . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products